These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 4147193)

  • 41. [Reduction of exercise inudced hyperventilation by blocking beta adrenergic receptors].
    Scheen A; Juchmes J; Cession-Fossion A
    C R Seances Soc Biol Fil; 1976; 170(1):220-3. PubMed ID: 9186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
    O'Connor PC; Finch MJ; Harron DW; Meredith PA; McDevitt DG; Shanks RG
    Br J Clin Pharmacol; 1985 Dec; 20(6):659-67. PubMed ID: 2868744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective beta adrenergic receptor antagonism in the anesthetized dog.
    Wasserman MA; Levy B
    J Pharmacol Exp Ther; 1974 Feb; 188(2):357-67. PubMed ID: 4149462
    [No Abstract]   [Full Text] [Related]  

  • 44. Levo-bunolol and propranolol: further evaluation of oral beta-blocking activity in conscious dogs.
    Commarato MA; Giardino EC; Kopia GA; Kaplan HR
    Arch Int Pharmacodyn Ther; 1977 Apr; 226(2):205-13. PubMed ID: 327960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Membrane stabilizing activity and beta-adrenoceptor antagonist-induced bradycardia in conscious dogs.
    Boucher M; Chapuy E; Duchêne-Marullaz P
    Eur J Pharmacol; 1992 Feb; 211(3):343-9. PubMed ID: 1352254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Isoprenaline antagonism of cardioselective beta-adrenergic receptor blocking agents on human and rat adipocytes.
    Harms HH; Van der Meer J
    Br J Clin Pharmacol; 1975 Aug; 2(4):311-5. PubMed ID: 9950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of propranolol and pindolol on the haemodynamic effects of papaverine, isoprenaline and noradrenaline in hypertensive patients.
    Chu D; Cocco G; Schweda E; Haeusler G; Strozzi C
    Eur J Clin Pharmacol; 1980 Aug; 18(2):141-6. PubMed ID: 7428794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of beta adrenergic blocking agents on plasma renin activity in the conscious rabbit.
    Weber MA; Thornell IR; Stokes GS
    J Pharmacol Exp Ther; 1974 Jan; 188(1):234-40. PubMed ID: 4148935
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of the effect of pindolol and propranolol on heart rate after acute and chronic administration.
    Finch MB; O'Connor PC; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1983 Apr; 15(4):431-4. PubMed ID: 6849778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiac and bronchial beta-adrenoceptor antagonistic potencies of atenolol, metoprolol, acebutolol, practolol, propranolol and pindolol in the anaesthetized dog.
    Harms HH; Spoelstra AJ
    Clin Exp Pharmacol Physiol; 1978; 5(1):53-9. PubMed ID: 25152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The blocking effects of propranolol, practolol and ICI-66082 on the peripheral vascular responses to isoprenaline.
    Hainsworth R; Karim F; Stoker JB; Harry JD
    Br J Pharmacol; 1973 Jun; 48(2):342P-343P. PubMed ID: 4147430
    [No Abstract]   [Full Text] [Related]  

  • 52. Investigations with beta-adrenoceptor blocking drugs in healthy volunteers.
    Aellig WH
    Acta Med Scand Suppl; 1977; 606():71-5. PubMed ID: 19932
    [No Abstract]   [Full Text] [Related]  

  • 53. Sustaining effects of bopindolol on inhibitory chronotropic actions in guinea pig atria.
    Hattori K; Suzuki J; Hosohata Y; Ohnuki T; Nakamura T; Watanabe K; Muramatsu I; Nagatomo T
    Pharmacology; 1999 Oct; 59(4):183-91. PubMed ID: 10474078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological studies with tiprenolol and propranolol in man.
    Kesteloot H; Sluyts R; Floor-Wieringa A; van Strik R
    Eur J Pharmacol; 1973 Mar; 21(3):257-63. PubMed ID: 4145318
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of tests of adrenergic beta-receptor blockade in man and their application to a comparison of the beta-blocking potency of propranolol and oxprenolol.
    Taylor SH; Majid PA; Sharma B
    Postgrad Med J; 1970 Nov; ():Suppl:57-60. PubMed ID: 4395459
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
    Thomas MS; Tattersfield AE
    Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparative studies of antihypertensive effects of several beta-blocking agents in conscious rats (author's transl)].
    Ozawa H; Watanabe H; Chen CS
    Nihon Yakurigaku Zasshi; 1978 Jan; 74(1):139-44. PubMed ID: 25230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hemodynamic effects of intravenous injection of beta-adrenergic inhibitor (Pindolol) in man].
    Scebat L; Rocha P; Ourbak P; Renais J; Lenègre J
    G Ital Cardiol; 1972; 2(5):626-35. PubMed ID: 4404052
    [No Abstract]   [Full Text] [Related]  

  • 60. Relevance of selectivity and non-selectivity in beta-adrenoceptor blocking drugs.
    Bonelli J
    Br J Clin Pharmacol; 1982; 13(Suppl 2):199S-200S. PubMed ID: 6125170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.